Oxyrase, Inc.
USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02A (Technologies FOR Adaptation TO Climate Change).
The verdict
According to USPTO PatentsView, Oxyrase ranks #42,208 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.
- #42,208
- of 49,997 US assignees by volume
- 32nd percentile
- by Innovation Score (29.7/100)
- 15.3
- avg claims per patent
- +400%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R42208 · US Corporation #42,208 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #42,208/49,997
- PHOTO-FINISH Outlander
- CPC-NARROW Y02A · 7 areas
- INNOV-THIN 29.7/100
- CLAIMS-RICH 15.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +400% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Outlander LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Oxyrase’s 29.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Oxyrase
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Oxyrase · this assignee 30
Oxyrase · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Oxyrase's Innovation Score is 29.7/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Oxyrase?
Each dot is one of Oxyrase’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oxyrase’s own 15.3 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Oxyrase's grants concentrate
Oxyrase, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 66.7% of grants classified under Y02A (Technologies FOR Adaptation TO Climate Change). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2018. By volume, Oxyrase sits between Outlander LLC and P4 Infrastructure, Inc..
Oxyrase's three-year grant acceleration
Oxyrase, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Oxyrase's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Outlander
Outlander LLC
6 patents
- Oxen
Oxen, Inc.
6 patents
- Oxycom Beheer B V
Oxycom Beheer B.V.
6 patents
- Oxygen Cloud
Oxygen Cloud, Inc.
6 patents
- P & P Optica
P & P Optica Inc.
6 patents
- P&M
P&M Co., Ltd.
6 patents
- P2S Media Group Oy
P2S Media Group Oy
6 patents
- P4 Infrastructure
P4 Infrastructure, Inc.
6 patents
- Oxyrase ◀
Oxyrase, Inc.
6 patents
What this shows Oxyrase holds 6 patents at rank #42,181, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Oxyrase
By rank, the assignees closest to #42,181 in granted patent volume.
Leaders in Y02A (Technologies FOR Adaptation TO Climate Change)
Other assignees with the most granted patents in Oxyrase's primary technology class.
- Monsanto Technology LLC 369 in class
- The Regents of the University of California 309 in class
- Dexcom, Inc. 263 in class
- Pioneer Hi-bred International, Inc. 186 in class
- Glaxosmithkline Biologicals SA 180 in class
- Massachusetts Institute of Technology 163 in class
- DOW Agrosciences LLC 156 in class
- The Board of Regents of the University of Texas System 133 in class
Oxyrase's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 32nd percentile higher than 32% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2020 | 2 | 33.3% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
Which technologies does Oxyrase, Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Oxyrase, Inc.'s patent record in context - here's where to go next.
- Oxyrase, Inc.'s lead technology class is Y02A (Technologies FOR Adaptation TO Climate Change), 66.7% of its portfolio - see every assignee active in that class. Explore Y02A
- Ranked #42,208 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Oxyrase, Inc. against Outlander LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.